PTGX - Protagonist Therapeutics, Inc - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - PTGX (1377121)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
27 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m
P5+2-0+16+29

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Share Price

Shares Traded

Shares Owned

Own chg

Value Traded

1d ret

1w ret

1m ret

6m ret

2018-05-17
PTGXCanaan X L.P.10%S - Sale$6.09-38,9682,116,552-2%-$237,358
D
2017-05-16
PTGXGiraudo BryanDirP - Purchase$6.46+10,00010,000New+$64,566
M
2018-05-14
PTGXCanaan X L.P.10%S - Sale$6.42-164,7472,155,520-7%-$1,058,375
2018-03-23
PTGXCanaan X L.P.10%S - Sale$20.71-59,9502,320,267-3%-$1,241,325
M
2018-03-20
PTGXCanaan X L.P.10%S - Sale$20.61-39,5182,380,217-2%-$814,398
M
2018-03-16
PTGXCanaan X L.P.10%S - Sale$20.55-20,3652,419,735-1%-$418,508
M
2018-03-13
PTGXCanaan X L.P.10%S - Sale$20.66-13,1552,440,100-1%-$271,768
D
2018-03-12
PTGXLiu David YChief Scientific OfficerS - Sale+OE$21.29-3,50015,028-19%-$74,500
D
2018-03-02
PTGXLiu David YChief Scientific OfficerS - Sale+OE$20.00-87513,322-6%-$17,500
D
2018-01-16
PTGXLiu David YChief Scientific OfficerS - Sale+OE$20.00-8753,822-19%-$17,500
D
2017-12-22
PTGXShames Richard S.Chief Medical OfficerS - Sale+OE$20.50-3,5290-100%-$72,345
D
2017-12-21
PTGXPatel Dinesh V Ph DPres, CEOS - Sale+OE$19.56-8,210190,437-4%-$160,570
D
2017-12-20
PTGXPatel Dinesh V Ph DPres, CEOS - Sale+OE$19.55-1,790190,437-1%-$34,987
D
2017-12-18
PTGXLiu David YChief Scientific OfficerS - Sale+OE$20.00-8753,822-19%-$17,500
D
2017-12-18
PTGXO'Neil Thomas P.CFOS - Sale+OE$20.00-8,0008,000-50%-$160,000
D
2017-11-30
PTGXLiu David YChief Scientific OfficerS - Sale+OE$20.00-8753,822-19%-$17,500
D
2017-11-13
PTGXLiu David YChief Scientific OfficerS - Sale+OE$16.97-7,0003,822-65%-$118,761
D
2017-10-05
PTGXShames Richard S.Chief Medical OfficerS - Sale+OE$19.00-2,0170-100%-$38,323
2017-09-12
PTGXShames Richard S.Chief Medical OfficerS - Sale$14.31-3,6870-100%-$52,753
D
2017-08-29
PTGXShames Richard S.Chief Medical OfficerS - Sale+OE$17.00-1,5121,865-45%-$25,704
D
2017-08-28
PTGXLiu David YChief Scientific OfficerS - Sale+OE$15.00-3,5002,000-64%-$52,500
D
2017-07-10
PTGXLiu David YChief Scientific OfficerS - Sale+OE$12.68-3,5002,000-64%-$44,380
D
2016-08-16
PTGXJohnson & Johnson10%P - Purchase$12.00+583,3332,449,183+31%+$6,999,996+1-6+23+29
D
2016-08-16
PTGXPapanek JulieDirP - Purchase$12.00+583,3332,453,255+31%+$6,999,996+2+1+14+29
D
2016-08-16
PTGXCanaan X L.P.Dir, 10%P - Purchase$12.00+583,3332,453,255+31%+$6,999,996+2+1+14+29
D
2016-08-16
PTGXShanafelt ArmenDir, 10%P - Purchase$12.00+583,3332,099,482+38%+$6,999,996+2+1+14+29
D
2016-08-16
PTGXLv Management Group, LLC10%P - Purchase$12.00+583,3332,099,482+38%+$6,999,996+2+1+14+29

Real-time CSV? Options? Alerts? Contact us!
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top